Recruiting soon
ALERT-ED

Emergency Department Patients At-Risk Awareness & Resources Linkage Program

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study AimThis study aims to increase awareness and resources for emergency department patients who are at risk of falling, with the goal of reducing fall-related emergency department visits.
What is being tested

ALERT-ED

Behavioral
Who is being recruted

Emergencies
+1

+ Pathologic Processes
+ Pathological Conditions, Signs and Symptoms
Over 65 Years
+3 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Prevention Study

Interventional
Study Start: December 2025
See protocol details

Summary

Principal SponsorUniversity of Colorado, Denver
Study ContactElizabeth M Goldberg, MD, ScMMore contacts
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner
Study start date: December 1, 2025Actual date on which the first participant was enrolled.

Falls are a major cause of injuries in older adults, often leading to repeated visits to the emergency department. Many older adults are not aware of fall prevention resources that can help reduce their risk of falls by up to 30%. Currently, patients at UCHealth emergency departments are screened for fall risk, but they rarely learn about their results or get directed to helpful resources. This study introduces ALERT-ED, a program designed to automatically notify patients of their fall risk screening results and refer them to nearby fall prevention programs. If successful, this could significantly improve patient health by making it easier for them to access necessary resources, and the approach could be applied to other health concerns such as transplant care or cancer. Participants in this study will receive an automated message about their risk of falls as soon as they arrive at the emergency department. This message will also include a referral to local fall prevention programs, which are based on proven methods to help reduce the occurrence of falls. The study will evaluate how effective this notification and referral system is in connecting patients with the resources they need. By making this process automated, it aims to ensure that more patients are informed about their health and can take action to prevent future falls, ultimately improving their quality of life.

Official TitleALERT-ED: Awareness and Linkage to Resources for At-Risk Emergency Department Patients 
NCT07028463
Principal SponsorUniversity of Colorado, Denver
Study ContactElizabeth M Goldberg, MD, ScMMore contacts
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details
20700 patients to be enrolledTotal number of participants that the clinical trial aims to recruit.
Prevention Study
Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.

How participants are assigned to different groups/arms
In this clinical study, participants are placed into groups randomly, like flipping a coin. This ensures that the study is fair and unbiased, making the results more reliable. By assigning participants by chance, researchers can better compare treatments without external influences.

Other Ways to Assign Participants
Non-randomized allocation: Participants are assigned based on specific factors, such as their medical condition or a doctor's decision.
None (Single-arm trial): If the study has only one group, all participants receive the same treatment, and no allocation is needed.

How treatments are given to participants
Participants are divided into different groups, each receiving a specific treatment at the same time. This helps researchers compare how well different treatments work against each other.

Other Ways to Assign Treatments
Single-group assignment: Everyone gets the same treatment.
Cross-over assignment: Participants switch between treatments during the study.
Factorial assignment: Participants receive different combinations of treatments.
Sequential assignment: Participants receive treatments one after another in a specific order, possibly based on individual responses.
Other assignment: Treatment assignment does not follow a standard or predefined design.

How the effectiveness of the treatment is controlled
In a non placebo-controlled study, no participants receive an inert substance (placebo) to compare outcomes. Instead, all participants receive either the experimental treatment or an alternative treatment (often the Standard of Care). This method allows researchers to compare the effects of the experimental treatment with those of a different active intervention, rather than a placebo.

Other Options
Placebo-Controlled: A placebo is used to compare the effects of the experimental treatment with those of an inert substance, isolating the true treatment effect.

How the interventions assigned to participants is kept confidential
Everyone involved in the study knows which treatment is being given. This is typically used when it's not possible or necessary to hide the treatment details from participants or researchers.

Other Ways to Mask Information
Single-blind: Participants do not know which treatment they are receiving, but researchers do.
Double-blind: Neither participants nor researchers know which treatment is given.
Triple-blind: Participants, researchers, and outcome assessors do not know which treatment is given.
Quadruple-blind: Participants, researchers, outcome assessors, and care providers all do not know which treatment is given.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
Over 65 YearsRange of ages for which participants are eligible to join.
Healthy volunteers not allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Emergencies
Pathologic Processes
Pathological Conditions, Signs and Symptoms
Disease Attributes
Criteria
2 inclusion criteria required to participate
65 years or older
Screens high risk falls on the Geriatric Fall assessment tool (as shown in protocol and used as standard practice in study ED)
1 exclusion criteria prevent from participating
Does not consent to follow up interview

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives
One single intervention group 

is designated in this study

This study does not include a placebo group 

Treatment Groups
Group I
Experimental
Patient receives link to the Livi Chatbot in After Visit Summary

Patient receives link to the Livi Chatbot in After Visit Summary
Study Objectives
Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 1 location
Suspended
UCHealthAurora, United StatesSee the location
Recruiting soonOne Study Center
;